# MDMA-Assisted Massed Exposure Therapy for PTSD

> **NCT07288151** · PHASE2 · RECRUITING · sponsor: **Emory University** · enrollment: 200 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** 3,4-Methylenedioxymethamphetamine (MDMA)
- **DRUG:** Placebo
- **BEHAVIORAL:** Massed Prolonged Exposure (PE)

## Key facts

- **NCT ID:** NCT07288151
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07288151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07288151, "MDMA-Assisted Massed Exposure Therapy for PTSD". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07288151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*